Skip Ribbon Commands
Skip to main content
Translate
Donations
menu iconMenu
search iconSearch

Detecting Fetal Chromosomal Defects Without Risk

Noninvasive sequencing is faster, cheaper and safer for mother and fetus, say researchers

May 06, 2014  |  

Chromosomal abnormalities that result in birth defects and genetic disorders like Down syndrome remain a significant health burden in the United States and throughout the world, with some current prenatal screening procedures invasive and a potential risk to mother and unborn child.

In a paper published online this week in the Early Edition of PNAS, a team of scientists at the University of California, San Diego School of Medicine and in China describe a new benchtop semiconductor sequencing procedure and newly developed bioinformatics software tools that are fast, accurate, portable, less expensive and can be completed without harm to mother or fetus.  

human karyotype

Human karyotype.

“We believe this approach could become the standard of care for screening of prenatal chromosomal abnormalities,” said Kang Zhang, MD, PhD, professor of ophthalmology, founding director of the Institute for Genomic Medicine at UC San Diego and a staff physician at the San Diego VA Healthcare System.

The incidence of chromosomal abnormalities – in numbers or structure – is one in 160 live births in the United States, higher in other countries. In China, for example, the rate is one in 60 live births. The effects of these abnormalities, known as aneuploidies, can be severe, from developmental delays and neurological disorders to infertility and death. The incidence rate rises with maternal age, most notably after age 35.

Current diagnoses of fetal aneuploidies often rely upon invasive tests that sample amniotic fluid or placental tissues for fetal DNA that can then be analyzed using a variety of complex and expensive methods, including full karyotyping in which the entire set of chromosomes is viewed microscopically. While highly reliable, these invasive tests may cause infections in the pregnant woman and pose as much as a 1 percent risk of miscarriage and fetal loss. Results are not available for one to two weeks, extending anxiety for families waiting for information. 

The new method relies upon massively parallel sequencing of cell-free fetal DNA using a benchtop semiconductor sequencing platform (SSP) called an Ion Torrent sequencer developed by Life Technologies. Cell-free fetal DNA is genetic material from the fetus that circulates naturally and freely in the mother’s bloodstream. It can be obtained through an ordinary blood draw, with SSP analysis achieved in less than four days.

To assess the SSP method, researchers tested 2,275 pregnant women. More than 500 participated in a retrospective analysis, undergoing full karyotyping to establish known chromosomal abnormalities followed by SSP testing. The remainder participated in a prospective study without prior karyotyping, and SSP testing results were then compared to karyotyping results. The sequencing and automated bioinformatics analyses were performed at iGenomics in Guangzhou, China.

“We used the retrospective study to establish the method and the prospective study to validate it,” said Zhang.

In the retrospective study, the researchers found that SSP detected multiple types of chromosomal abnormality with virtually 100 percent sensitivity and specificity compared to full karyotyping.

“To our knowledge, this is the first large-scale clinical study to systematically identify chromosomal aneuploidies based on cell-free fetal DNA using SSP,” said Zhang. “It provides an effective strategy for large-scale, noninvasive screenings in a clinical setting. It can be done in hospitals and outpatient clinics, more quickly and cheaply.”

Co-authors are Can Liao, Fang Fu, Ru Li, Yong-ling Zhang, Yan-mei Ou, Jian Li and Dong-zhi Li, Guangzhou Medical University, China; Ai-hua Yi, Jie-xia Yang, Jing Wu, Ming-qin Mai and Xiao-zhuang Zhang, Guangdong Women and Children Hospital, China; Chun-fang Peng, Yang-yi Chen, Dong-hong Luo and Hai-liang Liu, iGenomics Co., Guangzhou, China;  Rui Hou, Guangzhou Kang Rui Biological Pharmaceutical Technology Co, Guangzhou, China; Frances Wu, UCSD Institute for Genomic Medicine and UCSD Department of Ophthalmology; and Hongrong Luo, UCSD Institute for Genomic Medicine and UCSD Department of Ophthalmology and Sichuan University, China.

Funding for this research came, in part, from the National Natural Science Foundation of China, National Science Foundation for Young Scholars of China, National Natural Science Foundation of Guangdong, Key Project of Guangzhou Health Bureau, Major Project of Guangzhou Science and Technology and Information Bureau, 973 program and Burroughs Wellcome Fund.

# # #

Media contact: Scott LaFee, 619-543-6163, slafee@ucsd.edu




Media Contact

Related News

9/5/2014
To help get the word out that alcohol and pregnancy don’t mix, volunteers with the Southern California affiliate of the National Organization on Fetal Alcohol Syndrome (SoCal NOFAS) are handing out “P ...
8/11/2014
A recent study conducted by researchers at the University of California, San Diego School of Medicine and the University of Hawaii demonstrates a new approach to measuring early brain development of i ...
8/11/2014
During pregnancy, certain hormones trigger specialized mammary stem cells to create milk-producing cells essential to lactation. Scientists at the University of California, San Diego School of Medicin ...
6/23/2014
UC San Diego Health System’s doctors are the first fertility specialists in the county to use a new ultrasound technique to assess fallopian tubes by employing a mixture of saline and air bubbles that ...
6/19/2014
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report ...
5/5/2014
Researchers at the University of California, San Diego School of Medicine have discovered a genetic risk factor for premature birth. The risk factor is related to a gene that codes for a protein that ...
3/26/2014
Researchers at the University of California, San Diego School of Medicine and the Allen Institute for Brain Science have published a study that gives clear and direct new evidence that autism begins d ...
3/6/2014
In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), co ...


Share This Article



Follow Us